 | • レポートコード：MRC2304I0188 • 出版社/出版日：Persistence Market Research / 2023年1月24日 • レポート形態：英文、PDF、289ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,140,000 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,590,000 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査資料では、世界のトリプタミンAPI市場について調査・分析を行い、市場の現状と今後の展望を整理しています。本書は、エグゼクティブサマリー、市場概要、主要市場動向、付加価値のインサイト、市場背景、新型コロナウイルス感染症危機分析、需要分析・予測、価格分析・予測、市場規模分析・予測、グレード別（GMPグレード、非GMPグレード）分析、ソース別（天然、合成、生物合成）分析、用途別（臨床用、研究用）分析、地域別（北米、中南米、ヨーロッパ、東アジア、南アジア、オセアニア、中東・アフリカ）分析、市場構造分析、競争分析、仮定、調査手法など、以下の構成で掲載しています。また、Merck、Avra Synthesis Private Limited、Spectrum Chemical、Cayman Chemical Company (Matreya)、Tokyo Chemical Industry Co. Ltd.、Santa Cruz Biotechnology, Inc.、LGC Standards、Avra Synthesis Private Limited、SimSon Pharma Limited、Glentham Life、Clearsynth Labs、Otto Chemie Pvt. Ltd、Pharmaffiliates Analytics and Synthetics P. Ltd.、Psygen、Biosynthなどの企業情報が含まれています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・付加価値のインサイト ・市場背景 ・新型コロナウイルス感染症危機分析 ・需要分析・予測 ・価格分析・予測 ・市場規模分析・予測 ・世界のトリプタミンAPI市場規模：グレード別 - GMPグレードにおける市場規模 - 非GMPグレードにおける市場規模 ・世界のトリプタミンAPI市場規模：ソース別 - 天然トリプタミンAPIの市場規模 - 合成トリプタミンAPIの市場規模 - 生物合成性トリプタミンAPIの市場規模 ・世界のトリプタミンAPI市場規模：用途別 - 臨床用トリプタミンAPIの市場規模 - 研究用トリプタミンAPIの市場規模 ・世界のトリプタミンAPI市場規模：地域別 - 北米のトリプタミンAPI市場規模 - 中南米のトリプタミンAPI市場規模 - ヨーロッパのトリプタミンAPI市場規模 - 東アジアのトリプタミンAPI市場規模 - 南アジアのトリプタミンAPI市場規模 - オセアニアのトリプタミンAPI市場規模 - 中東・アフリカのトリプタミンAPI市場規模 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Tryptamines API Market: Scope of Report
The latest publication by Persistence Market Research on the global tryptamines API market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023 to 2033.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for tryptamines API services and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the tryptamines API market. Shareholders in the tryptamines API market, industry experts, investors, researchers, and reporters, as well as business enthusiasts can leverage insights and information presented in this Persistence Market Research study.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the tryptamines API market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the tryptamines API market offers information divided into four important segments — grade, source, application, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Grade
GMP Grade
Non-GMP Grade
Source
Natural
Synthetic
Bio-Synthetic
Application
Clinical Use
Research Use
Region
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for tryptamines APIs over the coming years?
How will changing trends influence the market?
How has the COVID-19 crisis influenced market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will influence the market?
How can companies in the tryptamines API market avail themselves of the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the tryptamines API market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the tryptamines API market are more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations
2.3. Inclusion And Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development/Innovation Trends
4. Value Added Insights
4.1. Production Capacity
4.2. Volume Consumption
4.3. Pricing Structure Assessment ($/Year)
4.3.1. Raw Material
4.3.2. Labor
4.3.3. Facility Overhead
4.3.4. Laboratory/QC/QA
4.3.5. Consumables
4.3.6. Utilities
4.4. Regulatory Scenario
4.5. Pipeline Assessment
4.6. Patent Analysis
4.7. PESTEL Analysis
4.8. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Industry Outlook
5.1.3. Global API Manufacturing Overview
5.2. Forecast Factors – Relevance & Impact
5.2.1. Growing Incidence of Neurological and Psychiatric Diseases
5.2.2. Applications of Tryptamines in Immunotherapy
5.2.3. Growing R&D on Antitumor Therapy
5.2.4. Global Growth of CDMOs
5.2.5. Rising Clinical Studies Using Tryptamines
5.2.6. Rising Demand from Downstream Industries
5.2.7. Raw Material Costs
5.2.8. Key Regulatory Dynamics
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. 2022 Market Scenario
6.2. COVID-19 and Impact Analysis
6.2.1. By Grade
6.2.2. By Source
6.2.3. By Compound
6.2.4. By Application
6.2.5. By Region
7. Global Tryptamines API Market Demand Volume (in Kgs) Analysis 2017–2022 and Forecast, 2023-2033
7.1. Historical Market Volume (Units) Analysis, 2017–2022
7.2. Current and Future Market Volume (Units) Projections, 2023–2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Tryptamines API Market Demand Pricing Analysis 2017–2022 and Forecast, 2023–2033
8.1. Regional Pricing Analysis
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.3.1. Pricing Assumptions
9. Global Tryptamines API Market Demand Value or Size (US$ Mn) Analysis 2017 – 2022 and Forecast, 2023–2033
9.1. Historical Market Value (US$ Mn) Analysis, 2017 – 2022
9.2. Current and Future Market Value (US$ Mn) Projections, 2023–2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Tryptamines API Market Analysis 2017–2022 and Forecast 2023-2033, By Grade
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Trend Analysis , By Grade, 2017–2022
10.3. Current and Future Market Size (US$ Mn) Trend Analysis Forecast, By Grade, 2023-2033
10.3.1. GMP Grade
10.3.2. Non-GMP Grade
10.4. Market Attractiveness Analysis By Grade
11. Global Tryptamines API Market Analysis 2017–2022 and Forecast 2023-2033, By Source
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Trend Analysis , By Source, 2017–2022
11.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast, By Source, 2023-2033
11.3.1. Natural
11.3.2. Synthetic
11.3.3. Bio-Synthetic
11.4. Market Attractiveness Analysis By Source
12. Global Tryptamines API Market Analysis 2017–2022 and Forecast 2023-2033, By Application
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Trend Analysis , By Application, 2017–2022
12.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast, By Application, 2023-2033
12.3.1. Clinical Use
12.3.2. Research Use
12.4. Market Attractiveness Analysis By Application
13. Global Tryptamines API Market Analysis 2017–2022 and Forecast 2023-2033, By Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis , By Region, 2017–2022
13.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast, By Region, 2023-2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa
13.4. Market Attractiveness Analysis By Region
14. North America Tryptamines API Market Analysis 2017–2022 and Forecast 2023-2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis , By Market Taxonomy, 2017–2022
14.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast, By Market Taxonomy, 2023-2033
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Grade
14.3.3. By Source
14.3.4. By Application
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Grade
14.4.3. By Source
14.4.4. By Application
14.5. Drivers and Restraints – Impact Analysis
14.6. Country Level Analysis & Forecast
14.6.1. U.S. Tryptamines API Market
14.6.1.1. Introduction
14.6.1.2. Market Analysis and Forecast by Market Taxonomy
14.6.1.2.1. By Grade
14.6.1.2.2. By Source
14.6.1.2.3. By Application
14.6.2. Canada Tryptamines API Market
14.6.2.1. Introduction
14.6.2.2. Market Analysis and Forecast by Market Taxonomy
14.6.2.2.1. By Grade
14.6.2.2.2. By Source
14.6.2.2.3. By Application
15. Latin America Tryptamines API Market Analysis 2017–2022 and Forecast 2023-2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2022
15.3. Current and Future Market Size (US$ Mn) Trend Analysis & Forecast By Market Taxonomy, 2023-2033
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Argentina
15.3.1.3. Mexico
15.3.1.4. Rest of Latin America
15.3.2. By Grade
15.3.3. By Source
15.3.4. By Application
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Grade
15.4.3. By Source
15.4.4. By Application
15.5. Drivers and Restraints – Impact Analysis
15.6. Country Level Analysis & Forecast
15.6.1. Brazil Tryptamines API Market
15.6.1.1. Introduction
15.6.1.2. Market Analysis and Forecast by Market Taxonomy
15.6.1.2.1. By Grade
15.6.1.2.2. By Source
15.6.1.2.3. By Application
15.6.2. Argentina Tryptamines API Market
15.6.2.1. Introduction
15.6.2.2. Market Analysis and Forecast by Market Taxonomy
15.6.2.2.1. By Grade
15.6.2.2.2. By Source
15.6.2.2.3. By Application
15.6.3. Mexico Tryptamines API Market
15.6.3.1. Introduction
15.6.3.2. Market Analysis and Forecast by Market Taxonomy
15.6.3.2.1. By Grade
15.6.3.2.2. By Source
15.6.3.2.3. By Application
16. Europe Tryptamines API Market Analysis 2017–2022 and Forecast 2023-2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2022
16.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2023-2033
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Nordic Countries
16.3.1.8. Russia
16.3.1.9. Rest of Europe
16.3.2. By Grade
16.3.3. By Source
16.3.4. By Application
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Grade
16.4.3. By Source
16.4.4. By Application
16.5. Drivers and Restraints – Impact Analysis
16.6. Country Level Analysis & Forecast
16.6.1. Germany Tryptamines API Market
16.6.1.1. Introduction
16.6.1.2. Market Analysis and Forecast by Market Taxonomy
16.6.1.2.1. By Grade
16.6.1.2.2. By Source
16.6.1.2.3. By Application
16.6.2. France Tryptamines API Market
16.6.2.1. Introduction
16.6.2.2. Market Analysis and Forecast by Market Taxonomy
16.6.2.2.1. By Grade
16.6.2.2.2. By Source
16.6.2.2.3. By Application
16.6.3. Italy Tryptamines API Market
16.6.3.1. Introduction
16.6.3.2. Market Analysis and Forecast by Market Taxonomy
16.6.3.2.1. By Grade
16.6.3.2.2. By Source
16.6.3.2.3. By Application
16.6.4. Spain Tryptamines API Market
16.6.4.1. Introduction
16.6.4.2. Market Analysis and Forecast by Market Taxonomy
16.6.4.2.1. By Grade
16.6.4.2.2. By Source
16.6.4.2.3. By Application
16.6.5. U.K. Tryptamines API Market
16.6.5.1. Introduction
16.6.5.2. Market Analysis and Forecast by Market Taxonomy
16.6.5.2.1. By Grade
16.6.5.2.2. By Source
16.6.5.2.3. By Application
16.6.6. BENULUX Tryptamines API Market
16.6.6.1. Introduction
16.6.6.2. Market Analysis and Forecast by Market Taxonomy
16.6.6.2.1. By Grade
16.6.6.2.2. By Source
16.6.6.2.3. By Application
16.6.7. Nordic Countries Tryptamines API Market
16.6.7.1. Introduction
16.6.7.2. Market Analysis and Forecast by Market Taxonomy
16.6.7.2.1. By Grade
16.6.7.2.2. By Source
16.6.7.2.3. By Application
16.6.8. Russia Tryptamines API Market
16.6.8.1. Introduction
16.6.8.2. Market Analysis and Forecast by Market Taxonomy
16.6.8.2.1. By Grade
16.6.8.2.2. By Source
16.6.8.2.3. By Application
17. South Asia Tryptamines API Market Analysis 2017–2022 and Forecast 2023-2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2022
17.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2023-2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Grade
17.3.3. By Source
17.3.4. By Application
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Grade
17.4.3. By Source
17.4.4. By Application
17.5. Drivers and Restraints – Impact Analysis
17.6. Country Level Analysis & Forecast
17.6.1. India Tryptamines API Market
17.6.1.1. Introduction
17.6.1.2. Market Analysis and Forecast by Market Taxonomy
17.6.1.2.1. By Grade
17.6.1.2.2. By Source
17.6.1.2.3. By Application
17.6.2. Indonesia Tryptamines API Market
17.6.2.1. Introduction
17.6.2.2. Market Analysis and Forecast by Market Taxonomy
17.6.2.2.1. By Grade
17.6.2.2.2. By Source
17.6.2.2.3. By Application
17.6.3. Malaysia Tryptamines API Market
17.6.3.1. Introduction
17.6.3.2. Market Analysis and Forecast by Market Taxonomy
17.6.3.2.1. By Grade
17.6.3.2.2. By Source
17.6.3.2.3. By Application
17.6.4. Thailand Tryptamines API Market
17.6.4.1. Introduction
17.6.4.2. Market Analysis and Forecast by Market Taxonomy
17.6.4.2.1. By Grade
17.6.4.2.2. By Source
17.6.4.2.3. By Application
18. East Asia Tryptamines API Market Analysis 2017–2022 and Forecast 2023-2033
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2022
18.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2023-2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Grade
18.3.3. By Source
18.3.4. By Application
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Grade
18.4.3. By Source
18.4.4. By Application
18.5. Drivers and Restraints – Impact Analysis
18.6. Country Level Analysis & Forecast
18.6.1. China Tryptamines API Market
18.6.1.1. Introduction
18.6.1.2. Market Analysis and Forecast by Market Taxonomy
18.6.1.2.1. By Grade
18.6.1.2.2. By Source
18.6.1.2.3. By Application
18.6.2. Japan Tryptamines API Market
18.6.2.1. Introduction
18.6.2.2. Market Analysis and Forecast by Market Taxonomy
18.6.2.2.1. By Grade
18.6.2.2.2. By Source
18.6.2.2.3. By Application
18.6.3. South Korea Tryptamines API Market
18.6.3.1. Introduction
18.6.3.2. Market Analysis and Forecast by Market Taxonomy
18.6.3.2.1. By Grade
18.6.3.2.2. By Source
18.6.3.2.3. By Application
19. Oceania Tryptamines API Market Analysis 2017–2022 and Forecast 2023-2033
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2022
19.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2023-2033
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Grade
19.3.3. By Source
19.3.4. By Compound
19.3.5. By Application
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Grade
19.4.3. By Source
19.4.4. By Application
19.5. Drivers and Restraints – Impact Analysis
19.6. Country Level Analysis & Forecast
19.6.1. Australia Tryptamines API Market
19.6.1.1. Introduction
19.6.1.2. Market Analysis and Forecast by Market Taxonomy
19.6.1.2.1. By Grade
19.6.1.2.2. By Source
19.6.1.2.3. By Application
19.6.2. New Zealand Tryptamines API Market
19.6.2.1. Introduction
19.6.2.2. Market Analysis and Forecast by Market Taxonomy
19.6.2.2.1. By Grade
19.6.2.2.2. By Source
19.6.2.2.3. By Application
20. Middle East and Africa (MEA) Tryptamines API Market Analysis 2017–2022 and Forecast 2023-2033
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2022
20.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2023-2033
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. North Africa
20.3.1.4. South Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Grade
20.3.3. By Source
20.3.4. By Application
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Grade
20.4.3. By Source
20.4.4. By Application
20.5. Drivers and Restraints – Impact Analysis
20.6. Country Level Analysis & Forecast
20.6.1. GCC Countries Tryptamines API Market
20.6.1.1. Introduction
20.6.1.2. Market Analysis and Forecast by Market Taxonomy
20.6.1.2.1. By Grade
20.6.1.2.2. By Source
20.6.1.2.3. By Application
20.6.2. Turkey Tryptamines API Market
20.6.2.1. Introduction
20.6.2.2. Market Analysis and Forecast by Market Taxonomy
20.6.2.2.1. By Grade
20.6.2.2.2. By Source
20.6.2.2.3. By Application
20.6.3. South Africa Tryptamines API Market
20.6.3.1. Introduction
20.6.3.2. Market Analysis and Forecast by Market Taxonomy
20.6.3.2.1. By Grade
20.6.3.2.2. By Source
20.6.3.2.3. By Application
20.6.4. North Africa Tryptamines API Market
20.6.4.1. Introduction
20.6.4.2. Market Analysis and Forecast by Market Taxonomy
20.6.4.2.1. By Grade
20.6.4.2.2. By Source
20.6.4.2.3. By Application
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Merck
21.3.1.1. Company Overview
21.3.1.2. Product Portfolio
21.3.1.3. Key Financials
21.3.1.4. SWOT Analysis
21.3.1.5. Key Developments
21.3.2. Avra Synthesis Private Limited
21.3.2.1. Company Overview
21.3.2.2. Product Portfolio
21.3.2.3. Key Financials
21.3.2.4. SWOT Analysis
21.3.2.5. Key Developments
21.3.3. Spectrum Chemical
21.3.3.1. Company Overview
21.3.3.2. Product Portfolio
21.3.3.3. Key Financials
21.3.3.4. SWOT Analysis
21.3.3.5. Key Developments
21.3.4. Cayman Chemical Company (Matreya)
21.3.4.1. Company Overview
21.3.4.2. Product Portfolio
21.3.4.3. Key Financials
21.3.4.4. SWOT Analysis
21.3.4.5. Key Developments
21.3.5. Tokyo Chemical Industry Co. Ltd.
21.3.5.1. Company Overview
21.3.5.2. Product Portfolio
21.3.5.3. Key Financials
21.3.5.4. SWOT Analysis
21.3.5.5. Key Developments
21.3.6. Santa Cruz Biotechnology, Inc.
21.3.6.1. Company Overview
21.3.6.2. Product Portfolio
21.3.6.3. Key Financials
21.3.6.4. SWOT Analysis
21.3.6.5. Key Developments
21.3.7. LGC Standards
21.3.7.1. Company Overview
21.3.7.2. Product Portfolio
21.3.7.3. Key Financials
21.3.7.4. SWOT Analysis
21.3.7.5. Key Developments
21.3.8. Avra Synthesis Private Limited
21.3.8.1. Company Overview
21.3.8.2. Product Portfolio
21.3.8.3. Key Financials
21.3.8.4. SWOT Analysis
21.3.8.5. Key Developments
21.3.9. SimSon Pharma Limited
21.3.9.1. Company Overview
21.3.9.2. Product Portfolio
21.3.9.3. Key Financials
21.3.9.4. SWOT Analysis
21.3.9.5. Key Developments
21.3.10. Glentham Life
21.3.10.1. Company Overview
21.3.10.2. Product Portfolio
21.3.10.3. Key Financials
21.3.10.4. SWOT Analysis
21.3.10.5. Key Developments
21.3.11. Clearsynth Labs
21.3.11.1. Company Overview
21.3.11.2. Product Portfolio
21.3.11.3. Key Financials
21.3.11.4. SWOT Analysis
21.3.11.5. Key Developments
21.3.12. Otto Chemie Pvt. Ltd
21.3.12.1. Company Overview
21.3.12.2. Product Portfolio
21.3.12.3. Key Financials
21.3.12.4. SWOT Analysis
21.3.12.5. Key Developments
21.3.13. Pharmaffiliates Analytics and Synthetics P. Ltd.
21.3.13.1. Company Overview
21.3.13.2. Product Portfolio
21.3.13.3. Key Financials
21.3.13.4. SWOT Analysis
21.3.13.5. Key Developments
21.3.14. Psygen
21.3.14.1. Company Overview
21.3.14.2. Product Portfolio
21.3.14.3. Key Financials
21.3.14.4. SWOT Analysis
21.3.14.5. Key Developments
21.3.15. Biosynth
21.3.15.1. Company Overview
21.3.15.2. Product Portfolio
21.3.15.3. Key Financials
21.3.15.4. SWOT Analysis
21.3.15.5. Key Developments
22. Assumptions and Acronyms Used
23. Research Methodology
